Lonza has announced its board of directors has appointed Christian Seufert as President of Capsules and Health Ingredients Division. The appointment will be effective from 1 July 2022. Seufert will succeed Claude Dartiguelongue as a member of the Lonza Group Executive Committee.
Seufert joins from BASF, where he has worked for the last 20 years. Most recently, he held the role of Senior VP for the Global Business Unit Pharma Solutions and represented the Nutrition & Health division in North and South America since 2018. In this role, Christian was responsible for driving organic growth with a focus on biologics and digital business models.
With his global team he delivered product line strategies for selected APIs and pharmaceutical excipients, improved operational excellence, and managed business continuity through the COVID-19 pandemic.
Christian holds a graduate degree in business administration and economics from the University of Hohenheim as well as Executive and post-graduate qualifications from INSEAD and IMD Business School (Lausanne, Switzerland). He is relocating from the US to live in Basel with his wife.
Albert M. Baehny, Chair, Lonza, said: “We extend a warm welcome to Christian as he joins the Lonza Group Executive Committee. Christian will lead a thriving Division which delivers strong cash generation and shows high long-term potential. His knowledge and understanding of our business will help us to achieve further improvements in operational excellence while continuing our growth journey.”
Pierre-Alain Ruffieux, CEO, Lonza, said: “Christian is uniquely placed to lead our CHI business, with a wealth of experience and expertise in both our operations as well as the industry in which we operate. Christian joins our leadership team as we continue to consolidate our leading market position and maintain our focus on driving accelerated growth and long-term success.”
